Page 4 - Blueprint Medicines Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Blueprint Medicines Co (NASDAQ:BPMC) Short Interest Update

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 4,540,000 shares, a growth of 6.8% from the April 15th total of 4,250,000 shares. Based on an average daily volume of 830,500 shares, […]

United statesZurcher kantonalbank zurich cantonalbankAriel hurleyKate havilandAllspring global investments holdingsBlueprint medicines corporationMirae asset global investments coSecurities exchange commissionYork mellon corpNeedham companyBlueprint medicines company profileBlueprint medicines coBlueprint medicinesGet free reportMedicines stock downExchange commission

Short Interest in Blueprint Medicines Co (NASDAQ:BPMC) Grows By 6 8%

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 4,540,000 shares, a growth of 6.8% from the April 15th total of 4,250,000 shares. Based on an average trading volume of 830,500 shares, the days-to-cover ratio […]

United statesChristopherk murrayPiper sandlerStifel nicolausBlueprint medicines coNeedham companyPrincipal financial group incUs bancorpAssociates corpMirae asset global investments coBlueprint medicines company profileSecurities exchange commissionCanada life assuranceBlueprint medicines corporationBlueprint medicinesGet free report

Blueprint Medicines (NASDAQ:BPMC) Upgraded to Market Perform by SVB Leerink

Blueprint Medicines (NASDAQ:BPMC) Upgraded to Market Perform by SVB Leerink
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesKate havilandChristopherk murrayPiper sandlerCompass wealth managementCutler groupBlueprint medicines corporationFinancial services group incHeadlands technologiesChina universal asset management coSecurities exchange commissionBlueprint medicinesFree reportMedicines trading downGet free reportExchange commission

The Goldman Sachs Group Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $168 00

The Goldman Sachs Group Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $168 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealand generalNew zealandMichael landsittelJeffreyw albersPiper sandlerNeedham companyBlueprint medicines corporationBlueprint medicines company profileSecurities exchange commissionPolar capital holdings plcVanguard group incGoldman sachs groupWellington management groupBlueprint medicinesFree report

Blueprint Medicines Co Forecasted to Earn FY2027 Earnings of $5 34 Per Share (NASDAQ:BPMC)

Blueprint Medicines Co Forecasted to Earn FY2027 Earnings of $5 34 Per Share (NASDAQ:BPMC)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesLeerink partnrsJeffreyw albersChristopherk murrayBlueprint medicines corporationPolar capital holdings plcBlueprint medicines coNeedham companyNorges bankBlueprint medicines company profileGoldman sachs groupSecurities exchange commissionBlueprint medicinesFree reportBlueprint medicineGet free report